Vivesto Stock

Vivesto OCF Margin

Operating Cash Flow Margin of Vivesto (VIVE.ST) as of Aug 10, 2026.

OCF Margin

0.00

Last updated:

Operating Cash Flow Margin of Vivesto is 2026 0.00 . Operating Cash Flow Margin of Vivesto was 2025 -7,932.71 % . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Vivesto since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Vivesto with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Vivesto

All Key Metrics — Vivesto